News

Dr Ruman Rahman, Associate Professor of Molecular Neuro-Oncology at the University of Nottingham, and IRC Investigator, contributed as a witness to the Oral Evidence Session for the All-Party Parliamentary Group on Brain Tumour (APPGBT) inquiry ‘Pathway to a Cure’ which was held virtually, Tuesday 22 March 2022. The panel...

The IRC’s Dr Ljiljana Fruk, Associate Professor in BioNano Engineering and Head of the BioNano Engineering Group at the University of Cambridge, is co-author of an academic textbook introducing the interdisciplinary and fast-developing field of bionanotechnology. Published by Cambridge University Press, the book titled ‘...

The first Cancer in Sight blog of the new year is by Prof Duncan Jodrell, Professor of Cancer Therapeutics at the University of Cambridge and one of the clinical leads for the IRC programme who explains the importance of a clearly defined clinical line of sight to the development of new therapeutics. The blog, titled ‘...

This month’s extended IRC Cancer in Sight blog is written by Stephen Lee who has survived two brain surgeries and lived with glioblastoma since his diagnosis 11 years ago, age 51 – only four months after he lost his brother to the same disease. In the blog titled ‘ Looking to the future – while living with glioblastoma’...